Awards

Leading Non-Commercial Dispensing Pharmacy  

We are honored to receive prestigious awards in the pharmaceutical and healthcare industry. They reflect our leadership and our mission of increasing medication access for patients nationwide. We always aim to surpass industry standards with our award-winning processes and our dedicated team. These recognitions strengthen our trustworthiness as a partner, building solid and credible relationships with pharmaceutical manufacturers, device partners, and healthcare providers. We are thankful for the chance to make a difference and will keep pursuing more success in the future.

Elevating Patient Experiences
Top Leaders Driving Impact Through Patient Assistance Programs in 2025

Explore how we are driving positive change in healthcare

Top Biotech & Pharmaceutical Company 2024

Medvantx awarded by Glassdoor.com

Top Companies Empowering Access to Healthcare in 2024

Medvantx awarded by InsightsCare Magazine

Top Innovative Companies to Watch in 2024

Our innovative solutions create a seamless connection between patients, providers and healthcare companies.

Best Non-Commercial Dispensing Pharmacy

Medvantx recognized in the Global Health and Pharma Awards 2023

5 Best Healthcare Companies to Watch

Medvantx recognized in 2023 by Silicon Review

Innovators of the Year 2023

Medvantx receives title from CEO Views for Innovators of the Year in 2023.

Top 10 Patient Engagement Solution Providers 2023

Through our innovative engagement model, we ensure medications are seamlessly delivered to to the patient or provider's home.

Fastest Growing Companies

Inc. Magazine has rated the Medvantx as one of the 5,000 fastest-growing private companies in the country.

Connect With Us

To receive more information about our products and services, or if you are a manufacturer who wants to schedule a demo with one of our Sales Representatives, please fill out this form.

"*" indicates required fields

First Name*
Last Name*
For patient inquiries, please click here.
This field is for validation purposes and should be left unchanged.